MAHWISH SADRUDDIN: Open Payments
NPI 1710473475 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 2 payments from 2 companies in 2025. Trend: 2023 $74 · 2024 $24 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 1 | $122 |
| Eisai Inc. | 1 | $35 |
Products named: Yorvipath, Lenvima.
Industry payments across TX — which companies pay providers there.
